Key points are not available for this paper at this time.
Elinzanetant is a very promising non-hormonal approach to a highly prevalent symptom constellation, with rapid onset and high efficacy. Wider indications are being explored in current Phase III trials.
Sassarini et al. (Tue,) studied this question.